Copyright Reports & Markets. All rights reserved.

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Overview

      • 1.1 Product Overview and Scope of Drugs for Vancomycin-Resistant Enterococcus Faecium
      • 1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Type
        • 1.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Daptomycin
        • 1.2.3 Linezolid
        • 1.2.4 Quinupristin/dalfopristin
        • 1.2.5 Ampicillin
        • 1.2.6 Chloramphenicol
        • 1.2.7 Others
      • 1.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Application
        • 1.3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Region
        • 1.3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size
        • 1.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (2014-2025)
        • 1.4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production (2014-2025)

      2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Competition by Manufacturers

      • 2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites, Area Served, Product Types
      • 2.5 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Competitive Situation and Trends
        • 2.5.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Rate
        • 2.5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Market Share by Regions

      • 3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Market Share by Regions
      • 3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Production
        • 3.4.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth Rate (2014-2019)
        • 3.4.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Production
        • 3.5.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drugs for Vancomycin-Resistant Enterococcus Faecium Production (2014-2019)
        • 3.6.1 China Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth Rate (2014-2019)
        • 3.6.2 China Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Production (2014-2019)
        • 3.7.1 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption by Regions

      • 4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption by Regions
      • 4.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption (2014-2019)
      • 4.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption (2014-2019)
      • 4.4 China Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption (2014-2019)
      • 4.5 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption (2014-2019)

      5 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price Trend by Type

      • 5.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Market Share by Type (2014-2019)
      • 5.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Type (2014-2019)
      • 5.4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth by Type (2014-2019)

      6 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Analysis by Applications

      • 6.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drugs for Vancomycin-Resistant Enterococcus Faecium Business

      • 7.1 Alchemia Limited
        • 7.1.1 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Alvogen
        • 7.2.1 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Aphios Corporation
        • 7.3.1 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Cellceutix Corporation
        • 7.4.1 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.4.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Enanta Pharmaceuticals
        • 7.5.1 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Helix BioMedix
        • 7.6.1 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.6.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 LegoChem Biosciences
        • 7.7.1 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.7.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Lytix Biopharma
        • 7.8.1 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.8.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 MGB Biopharma Limited
        • 7.9.1 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.9.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Microbiotix
        • 7.10.1 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Production Sites and Area Served
        • 7.10.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction, Application and Specification
        • 7.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturing Cost Analysis

      • 8.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium
      • 8.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Distributors List
      • 9.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

      • 11.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue Forecast
        • 11.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price and Trend Forecast (2019-2025)
      • 11.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast (2019-2025)
        • 11.3.3 China Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast (2019-2025)
      • 11.4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Drugs for Vancomycin-Resistant Enterococcus Faecium market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Drugs for Vancomycin-Resistant Enterococcus Faecium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Vancomycin-Resistant Enterococcus Faecium market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Alchemia Limited
        Alvogen
        Aphios Corporation
        Cellceutix Corporation
        Enanta Pharmaceuticals
        Helix BioMedix
        LegoChem Biosciences
        Lytix Biopharma
        MGB Biopharma Limited
        Microbiotix

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Daptomycin
        Linezolid
        Quinupristin/dalfopristin
        Ampicillin
        Chloramphenicol
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now